Navigation Links
Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO

products or product candidates; -- the Company's ability to enter into and successfully execute license and collaborative agreements, if any; -- the adequacy of the Company's capital resources and cash flow projections, and the Company's ability to obtain sufficient financing to maintain the Company's planned operations; -- the adequacy of the Company's patents and proprietary rights; -- the impact of litigation that has been brought against the Company and its officers and directors and any proposed settlement of such litigation; -- the Company's ability to regain compliance with the NASDAQ's listing qualifications, or its ability to successfully appeal the NASDAQ delisting; and -- the other risks described under Certain Risks and Uncertainties Related to the Company's Business, as contained in the Company's Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2006 and its most recent quarterly report on Form 10-Q.

     CONTACT:

     For Genta Incorporated

     Tara Spiess/Andrea Romstad

     TS Communications Group, LLC

     (908) 286-3980

     

info@genta.com

CONTACT: Tara Spiess or Andrea Romstad, both of TS Communications Group,LLC, +1-908-286-3980, , for Genta Incorporated info@genta.com

Web site: http://www.genta.com/http://www.idispharma.com/http://www.genta.com//

Ticker Symbol: (NASDAQ-NMS:GNTA)


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:5/28/2015)... Research and Markets( http://www.researchandmarkets.com/research/324sfl/global_biomedical ) has ... Metal Market 2015-2019" report to their offering. ... grow at a CAGR of 7.27% over the ... for a number of applications in the Medical ... titanium-based alloys, cobalt-based alloys, nitinol, magnesium and related ...
(Date:5/28/2015)... 28, 2015 A new report ... Industry Analysis, Trends, Opportunities, Growth and Forecast, 2014-2020", forecasts ... by 2020. The secondary syphilis testing would continue to ... Latin America , Middle East ... accounted for about 43% revenue share of the global ...
(Date:5/28/2015)... , May 28, 2015 The ... the Commission,s antitrust suit charging Cephalon, Inc. with ... drug Provigil. The settlement ensures that Teva Pharmaceutical ... make a total of $1.2 billion available to ... who overpaid because of Cephalon,s illegal conduct.  ...
Breaking Medicine Technology:Global Biomedical Metal Market 2015-2019 with Biomet, Dentsply, Invibio & Wright Medical Group Dominating 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 2FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 3
(Date:5/28/2015)... 2015 Ticket Down is a reputable source ... Mexico and Argentina in early September. , Two ... compete on the pitch at AT&T Stadium in Arlington/Dallas, TX. ... international friendly on Tuesday, September 8th at 9 p.m. The ... the world including some of the most loved players in ...
(Date:5/28/2015)... VA (PRWEB) May 28, 2015 ZH ... announced today that it is releasing BlueEHS, the Electronic ... Amazon Machine Image for the benefit of all AWS ... of BlueEHS, a first of its kind, Freemium, SaaS, ... Electronic Health Records (EHR) with an integrated practice management ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Dr. Paul ... surgeons , has announced that the new Houston Surgery ... American Association of Accreditation of Ambulatory Surgery Facilities awarded ... center . , According to Dr. Vitenas, the ... the standards of a Class C ambulatory surgery facility. ...
(Date:5/28/2015)... Beverly Hills, CA (PRWEB) May 28, 2015 ... a novel interactive keratoconus web application to ... Keratoconus has expanded in the last few years. This ... Even eye doctors are not aware of the nuances ... the Khanna Vision Institute, realized that websites can be ...
(Date:5/28/2015)... lifeIMAGE announced today that it has ... Cambia Health Solutions (Portland, Ore.), a nonprofit ... by creating a person-focused and economically sustainable system. lifeIMAGE, ... medical imaging, will use this financing to expand resources ... its network capabilities and implement the next phases of ...
Breaking Medicine News(10 mins):Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 3Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 3Health News:Dr. Paul Vitenas’ New Houston Surgery Center Receives AAAASF Accreditation 2Health News:Dr.Khanna Announced the Release of an Interactive Web Application for Keratoconus Treatment 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 2Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 3Health News:Cambia Health Solutions Leads New Round of Investment in lifeIMAGE 4
... ... the dangers of cycling injuries and urges caution on the roads , ... (PRWEB) June 14, 2010 -- National Accident Helpline is urging cyclists ... is seeing an increasing number of people take to their bikes, often for the first time ...
... ... non-smoking environment in all 231 guest rooms and 17,000 sq feet of meeting space, effective ... Silver ... has taken one more step to “going green”, effective June 14 the Hotel will be ...
... Young men who attempt suicide before age 18 are ... girlfriends or wives, including hitting and injuring their partners, according ... further evidence of the need for intervention with suicidal teens. ... neighborhoods who were assessed yearly from ages 10 to 32, ...
... ... ... to describe Dan McGehee’s third attempt at the 100-mile cycling track world record . He ... Today, he missed the record by only 4 minutes and 57 seconds. At noon, he was ...
... ... is proud to announce the relaunch of their website personalcarewholesaler.com, due to popular demand ... redesigned user-friendly website offers wholesale pricing on thousands of personal care products. , ... (PRWEB) June 13, 2010 ...
... but potential danger to the blood supply, but urge more research ... of Health and Human Services panel of experts on Friday voted ... advocating for more research on the controversial issue. , The current ... of the AIDS crisis -- prevents any man who since 1977 ...
Cached Medicine News:Health News:Break The Injury Cycle, Says National Accident Helpline 2Health News:Teen boys who attempted suicide more like to abuse partners as adults 2Health News:Teen boys who attempted suicide more like to abuse partners as adults 3Health News:American Doctor Misses World Cycling Record by 4 minutes, 57 Seconds 2Health News:Wholesale Pricing on Health & Beauty Products Now Available Nationwide at PersonalCareWholesaler.com 2Health News:U.S. Panel Upholds Ban on Gay Men as Blood Donors 2Health News:U.S. Panel Upholds Ban on Gay Men as Blood Donors 3
Hartman Mosquito forceps, straight serrated jaws, ring handle, dull finish, overall length 75 mm....
Curved 21 mm serrated jaws. Ring handle with ratchet lock and dull finish. Most popular size or model. Overall length 4.7 inches...
Shafts angled 45 degrees with 10 mm jaws. Serrated handle with polished finish. Crisscross serrated jaws. Most popular size or model....
Straight shafts with 13 mm crisscross serrated platform with polished finish. Wide serrated handle....
Medicine Products: